Skip to content

How Different Levels of CPAP Affect Oxygen Delivery and Lung Expansion in Preterm Infants

Oxygen Delivery in CPAP and Its Relationship With Regional Lung Ventilation in Preterm Infants

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07674953
Enrollment
10
Registered
2026-06-30
Start date
2026-04-15
Completion date
2027-06-01
Last updated
2026-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Distress of Newborn, Respiratory Distress Syndrome (Neonatal)

Keywords

respiratory distress syndrome, CPAP, preterm infant, effective oxygen delivery

Brief summary

With this study, it is expected to learn more about preterm babies on breathing support with nasal continuous positive airway pressure (nCPAP). To gain more information on how much oxygen is actually delivered to the baby from the nCPAP machine.

Detailed description

This study will tell more about a specific method of breathing support used frequently with preterm babies called nasal continuous positive airway pressure (nCPAP). It helps the baby breathe by providing air pressure and a certain amount of oxygen. It is very important for the baby's health to provide only as much oxygen as they need. With this study, it is expected to learn if the amount of oxygen ordered by a doctor on the nCPAP machine changes when it reaches the baby's airway, and if the amount of oxygen changes depending on how much air pressure the doctor provides. The answers to these questions, are not known, because special measurements are required that are difficult to know while a baby is on nCPAP. This study will collect these special measurements

Interventions

DEVICEEffective oxygen delivery and lung expansion measurement

This intervention arm will involve any infant who is already on nCPAP. It will involve placing a catheter in the infant's oropharynx and wrapping soft EIT bands around the infants chest to measure effective oxygen delivery and lung expansion, respectively.

Sponsors

University of Arkansas
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Gestational age at birth must be less than 35 weeks of completed gestation as documented in the subject's initial history and physical * The infant must be stable while receiving nasal CPAP at any pressure level at the time of study * The infant must be receiving 22-40% at the time of the study

Exclusion criteria

* Oxygen requirements greater than 40% at time of enrollment * currently receiving invasive ventilation or not requiring ventilatory support * Major congenital anomalies of the heart and/or lungs

Design outcomes

Primary

MeasureTime frameDescription
Inspired OxygenSampling will occur at three separate points within a thirty minute time frame for each enrolled infant.Percent of oxygen delivered to the back of the infant's mouth. This will be measured by placing a small plastic tube in the back of the infant's mouth and sampling the air while the infant is receiving several different pressure levels of CPAP.

Secondary

MeasureTime frameDescription
Lung VolumeLong volume will be continuously monitored throughout the 30 minute duration of the study for each enrolled infant.Using Electrical Impedance Tomography bands, the infant's lung volume will be monitored at several different CPAP pressure levels. These bands wrap around the infant's chest and measure lung volume using mild electrical currents.

Countries

United States

Contacts

CONTACTNicholas A Rowley, MD
NARowley@uams.edu940-230-5002

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 1, 2026